July, 02 2019
Giving healthcare companies the exposure they deserve. Every Tuesday.
BioTuesdays by Kilmer Lucas


Helius Medical rolling out PoNS treatment for mmTBI in Canada

Helius Medical Technologies (NASDAQ:HSDT; TSX:HSM) is transitioning from a development- to commercial-stage company as it rolls out its Health Canada-cleared PoNS medical device for the treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury (mmTBI), in conjunction with physical therapy.

“Our PoNS (Portable Neuromodulation Stimulator) represents a first mover advantage, with demonstrated safety and efficacy, in a market with few viable options,” Philippe Deschamps, chairman, president and CEO, says in an interview with BioTuesdays.

“After an initial medical event, very often a car accident, TBI can present significant long-term disabilities and challenges to the individual, family, and society,” Mr. Deschamps points out. “After an initial course of physical therapy, the standard of care, patients very often plateau in their recovery and thereafter, are disabled to some extent for the rest if their lives.”
Read the Story




Submits IND for CRV431 for NASH



Dova Pharmaceuticals

Gets FDA sNDA approval for thrombocytopenia drug


Titan Pharma

Titan Pharma, Molteni receive European regulatory okay for Probuphine



Joining Shoppers Drug Mart and TruTrace medical cannabis verification pilot

More Briefs

Wall Street News

About BioTuesdays

BioTuesdays was created in 2009 by Kilmer Lucas, a leading healthcare-only investor relations firm. Employing a unique "outsourced in-house" partnership model, Kilmer Lucas designs and executes customized IR & PR programs for its drug development, medical device, cell therapy, diagnostics and healthcare services clients. But, most of BioTuesdays' content isn't client-driven. Rather, our mission is to give as many great healthcare companies and their stories as much exposure as we can.
Want to be featured in BioTuesdays? Get in touch with us.
Copyright © 2019 Kilmer Lucas, All rights reserved.
You are receiving this email because you signed up for the BioTuesdays newsletter.
Privacy Policy

PO Box 297
Carlisle, ON L0R 1H0 

subscribe | unsubscribe | update your preferences